AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With...(on this important initiative said Timot...)

Date:6/1/2009

on this important initiative," said Timothy P. Walbert, president and chief executive officer, Horizon Therapeutics. "For many physicians and their patients, NSAID-associated GI ulcers are rarely discussed, and when they are it is often too late. Connect to Protect is an important step to increase awareness of the problem and provide education and resources to address it."

About NSAIDs and GI Toxicity

It is estimated that more than 60 million Americans use NSAIDs regularly, resulting in clinically significant upper GI events in one to two percent of users. NSAIDs, most often used for the treatment of arthritis and pain, block enzymes and reduce prostaglandins throughout the body and as a consequence, ongoing inflammation, pain and fever are reduced. Since the prostaglandins that protect the stomach are reduced, NSAIDs often cause ulcers in the stomach. It is estimated that GI hemorrhages due to NSAID use account for approximately 60,000-120,000 hospital admissions annually. Though difficult to quantify, available reports suggest that deaths from NSAID-related GI events vary from 3,200 to more than 16,500 per year in the United States.

For more information on the risks of chronic NSAID use and ways to avoid or reduce those risks, please visit www.connecttoprotect.com. In addition to facts on the risks of NSAID use, there are discussion guides for physicians and their patients about avoiding or reducing risks associated with chronic NSAIDs.

About the AGA Institute

The American Gastroenterological Association (AGA) is dedicated to the mission of advancing the science and practice of gastroenterology. Founded in 1897, the AGA is one of the oldest medical-specialty societies in the U.S. Comprised of two non-profit organizations -- the AGA and the AGA Institute -- our more than 17,000 members include physicians
'/>"/>

SOURCE Horizon Therapeutics, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
4. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
5. Solazyme Selected for National Institute of Standards and Technology Award
6. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. National Institutes of Health Awards $25.5M Contract to SRA
9. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
10. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
11. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus